| Bitan Ghosh, MD | |
|
10745 Westside Way Ste 125, Alpharetta, GA 30009-7635 | |
| (770) 410-4610 | |
| (888) 990-1674 |
| Full Name | Bitan Ghosh |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 10745 Westside Way Ste 125, Alpharetta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831456318 | NPI | - | NPPES |
| NC2809 | Medicaid | SC | |
| 1831456318 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2016-00204 (North Carolina) | Secondary |
| 207R00000X | Internal Medicine | 078626 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summa Health System | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summa Physicians Inc | 2961303532 | 640 |
News Archive
A new study has been published in the journal Vaccines that deals with the present state of research on using mAbs for the treatment of the COVID-19 disease. Many clinical trials are being conducted to evaluate the efficacy and safety of several newly designed mAbs. Some of the mAbs are directed towards immune system responses, i.e., non-SARS-CoV-2 specific mAbs, while others are devised to neutralize the SARS-CoV-2 protein structure, i.e., SARS-CoV-2 specific mAbs.
BeiGene (Beijing), Co., Ltd., today announced dose administration for the first patient in a Phase 1 study of BGB-283 in patients with B-RAF or K-RAS mutations. BGB-283 is an investigational, oral, selective, potent second generation inhibitor of B-RAF, making it a targeted therapeutic candidate to potentially treat and bring benefit to patients with cancers that harbor BRAF mutations and/or aberrations in the RAS-MAPK (mitogen-activated protein kinase) pathway.
The placenta uses a cloaking device similar to that used by parasites to avoid detection by the mother's immune system. MRC funded scientists looking to develop a diagnostic test for pre-eclampsia, a major and potentially fatal cause of fetal and maternal illness, made the amazing discovery which could have far reaching implications.
Ionizing radiation is not without danger to human populations. Indeed, exposure to nuclear radiation leads to an increase in male births relative to female births, according to a new study by Hagen Scherb and Kristina Voigt from the Helmholtz Zentrum München.
On Saturday, April 28, a 5-month-old baby received the 100th heart transplant performed at Seattle Children's Hospital, a significant milestone for him as well as the hospital's Heart Center and Heart Transplant Program teams.
› Verified 2 days ago
| Entity Name | Summa Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235167719 PECOS PAC ID: 2961303532 Enrollment ID: O20040116000295 |
News Archive
A new study has been published in the journal Vaccines that deals with the present state of research on using mAbs for the treatment of the COVID-19 disease. Many clinical trials are being conducted to evaluate the efficacy and safety of several newly designed mAbs. Some of the mAbs are directed towards immune system responses, i.e., non-SARS-CoV-2 specific mAbs, while others are devised to neutralize the SARS-CoV-2 protein structure, i.e., SARS-CoV-2 specific mAbs.
BeiGene (Beijing), Co., Ltd., today announced dose administration for the first patient in a Phase 1 study of BGB-283 in patients with B-RAF or K-RAS mutations. BGB-283 is an investigational, oral, selective, potent second generation inhibitor of B-RAF, making it a targeted therapeutic candidate to potentially treat and bring benefit to patients with cancers that harbor BRAF mutations and/or aberrations in the RAS-MAPK (mitogen-activated protein kinase) pathway.
The placenta uses a cloaking device similar to that used by parasites to avoid detection by the mother's immune system. MRC funded scientists looking to develop a diagnostic test for pre-eclampsia, a major and potentially fatal cause of fetal and maternal illness, made the amazing discovery which could have far reaching implications.
Ionizing radiation is not without danger to human populations. Indeed, exposure to nuclear radiation leads to an increase in male births relative to female births, according to a new study by Hagen Scherb and Kristina Voigt from the Helmholtz Zentrum München.
On Saturday, April 28, a 5-month-old baby received the 100th heart transplant performed at Seattle Children's Hospital, a significant milestone for him as well as the hospital's Heart Center and Heart Transplant Program teams.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bitan Ghosh, MD Po Box 601643, Charlotte, NC 28260-1643 Ph: (704) 302-9300 | Bitan Ghosh, MD 10745 Westside Way Ste 125, Alpharetta, GA 30009-7635 Ph: (770) 410-4610 |
News Archive
A new study has been published in the journal Vaccines that deals with the present state of research on using mAbs for the treatment of the COVID-19 disease. Many clinical trials are being conducted to evaluate the efficacy and safety of several newly designed mAbs. Some of the mAbs are directed towards immune system responses, i.e., non-SARS-CoV-2 specific mAbs, while others are devised to neutralize the SARS-CoV-2 protein structure, i.e., SARS-CoV-2 specific mAbs.
BeiGene (Beijing), Co., Ltd., today announced dose administration for the first patient in a Phase 1 study of BGB-283 in patients with B-RAF or K-RAS mutations. BGB-283 is an investigational, oral, selective, potent second generation inhibitor of B-RAF, making it a targeted therapeutic candidate to potentially treat and bring benefit to patients with cancers that harbor BRAF mutations and/or aberrations in the RAS-MAPK (mitogen-activated protein kinase) pathway.
The placenta uses a cloaking device similar to that used by parasites to avoid detection by the mother's immune system. MRC funded scientists looking to develop a diagnostic test for pre-eclampsia, a major and potentially fatal cause of fetal and maternal illness, made the amazing discovery which could have far reaching implications.
Ionizing radiation is not without danger to human populations. Indeed, exposure to nuclear radiation leads to an increase in male births relative to female births, according to a new study by Hagen Scherb and Kristina Voigt from the Helmholtz Zentrum München.
On Saturday, April 28, a 5-month-old baby received the 100th heart transplant performed at Seattle Children's Hospital, a significant milestone for him as well as the hospital's Heart Center and Heart Transplant Program teams.
› Verified 2 days ago
Jeffrey Obiora, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3180 N Point Pkwy Ste 303, Alpharetta, GA 30005 Phone: 678-205-9004 | |
Dr. Jay Arthur Cherner, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 3330 Preston Ridge Rd, Suite 220, Alpharetta, GA 30005 Phone: 770-410-1600 Fax: 770-410-0006 | |
Randy Turkel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11600 Atlantis Place, Suite B, Alpharetta, GA 30022 Phone: 770-664-4449 Fax: 770-777-6496 | |
Xiaowen Wu, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 10800 Jones Bridge Rd, Ste A, Alpharetta, GA 30022 Phone: 678-867-0135 Fax: 678-867-0137 | |
Dr. Justin Chen, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 2575 Northwinds Pkwy, Alpharetta, GA 30009 Phone: 800-930-0748 | |
Irfan Ali Syed, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3584 Old Milton Pkwy, Alpharetta, GA 30005 Phone: 678-691-3388 Fax: 678-395-7702 | |
Arezou Fatemi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3180 N Point Pkwy, Ste 303, Alpharetta, GA 30005 Phone: 678-205-9004 Fax: 678-205-9005 |